Characterization of varicella-zoster virus-encoded ORF0 gene-Comparison of parental and vaccine strains

Virology

Volumn 405, Issue 2, 2010, Pages 280-288

  Koshizuka, Tetsuo ^a   Ota, Megumi ^a,b   Yamanishi, Koichi ^a   Mori, Yasuko ^a,b  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Attenuation; ORF0; POka; Vaccine; VOka; VZV

Indexed keywords

AMINO ACID; CYTOSINE; THYMINE; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE MUTATION; GLYCOSYLATION; HUMAN; HUMAN CELL; HYDROPHOBICITY; MOLECULAR WEIGHT; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DOMAIN; STRAIN DIFFERENCE; VARICELLA ZOSTER VIRUS; VIRION; VIRUS ATTENUATION; VIRUS MUTANT; VIRUS PARTICLE; VIRUS PLAQUE; VIRUS RECOMBINANT; VIRUS STRAIN; WILD TYPE;

CELL LINE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; MUTATION; OPEN READING FRAMES; RECOMBINATION, GENETIC; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES; VIRION;

HUMAN HERPESVIRUS 3;

EID: 77955662202     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.06.016     Document Type: Article

References (35)

1. Abendroth A., Lin I., Slobedman B., Ploegh H., Arvin A.M. Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. J. Virol. 2001, 75:4878-4888.
2. Arvin A.M. Varicella vaccine: genesis, efficacy, and attenuation. Virology 2001, 284(2):153-158.
3. Borgese N., Colombo S., Pedrazzini E. The tale of tail-anchored proteins: coming from the cytosol and looking for a membrane. J. Cell Biol. 2003, 161(6):1013-1019.
4. Chaves S.S., Haber P., Walton K., Wise R.P., Izurieta H.S., Schmid D.S., Seward J.F. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J. Infect. Dis. 2008, 197(Suppl 2):S170-S177.
5. Cohen J.I., Straus S.E., Arvin A.M. Varicella-zoster virus replication, pathogenesis, and management. Fields Virology 2007, 2773-2818. Lippincott-Williams & Wilkins, Philadelphia. 4th. edition. D.M. Knipe, P.M. Howley (Eds.).
6. Dorig R.E., Marcil A., Chopra A., Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993, 75(2):295-305.
7. Erlenhofer C., Duprex W.P., Rima B.K., ter Meulen V., Schneider-Schaulies J. Analysis of receptor (CD46, CD150) usage by measles virus. J. Gen. Virol. 2002, 83(Pt 6):1431-1436.
8. Gomi Y., Imagawa T., Takahashi M., Yamanishi K. Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity. J. Med. Virol. 2000, 61(4):497-503.
9. Gomi Y., Sunamachi H., Mori Y., Nagaike K., Takahashi M., Yamanishi K. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J. Virol. 2002, 76(22):11447-11459.
10. High S., Abell B.M. Tail-anchored protein biosynthesis at the endoplasmic reticulum: the same but different. Biochem. Soc. Trans. 2004, 32(Pt 5):659-662.
11. Hirokawa T., Boon-Chieng S., Mitaku S. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics 1998, 14(4):378-379.
12. Jarosinski K.W., Margulis N.G., Kamil J.P., Spatz S.J., Nair V.K., Osterrieder N. Horizontal transmission of Marek's disease virus requires US2, the UL13 protein kinase, and gC. J. Virol. 2007, 81(19):10575-10587.
13. Kanegae Y., Lee G., Sato Y., Tanaka M., Nakai M., Sakaki T., Sugano S., Saito I. Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucleic Acids Res. 1995, 23(19):3816-3821.
14. Kemble G.W., Annunziato P., Lungu O., Winter R.E., Cha T.A., Silverstein S.J., Spaete R.R. Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells. J. Virol. 2000, 74(23):11311-11321.
15. Koshizuka T., Goshima F., Takakuwa H., Nozawa N., Daikoku T., Koiwai O., Nishiyama Y. Identification and characterization of the UL56 gene product of herpes simplex virus type 2. J. Virol. 2002, 76(13):6718-6728.
16. Koshizuka T., Sadaoka T., Yoshii H., Yamanishi K., Mori Y. Varicella-zoster virus ORF1 gene product is a tail-anchored membrane protein localized to plasma membrane and trans-Golgi network in infected cells. Virology 2008, 377(2):289-295.
17. Kutay U., Hartmann E., Rapoport T.A. A class of membrane proteins with a C-terminal anchor. Trends Cell Biol. 1993, 3(3):72-75.
18. Kyte J., Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 1982, 157(1):105-132.
19. Mettenleiter T.C. Herpesvirus assembly and egress. J. Virol. 2002, 76(4):1537-1547.
20. Moffat J.F., Zerboni L., Kinchington P.R., Grose C., Kaneshima H., Arvin A.M. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 1998, 72(2):965-974.
21. Nagaike K., Mori Y., Gomi Y., Yoshii H., Takahashi M., Wagner M., Koszinowski U., Yamanishi K. Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine 2004, 22(29-30):4069-4074.
22. Narayanan K., Williamson R., Zhang Y., Stewart A.F., Ioannou P.A. Efficient and precise engineering of a 200kb beta-globin human/bacterial artificial chromosome in E. coli DH10B using an inducible homologous recombination system. Gene Ther. 1999, 6(3):442-447.
23. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108(2):193-199.
24. Okuno T., Yamanishi K., Shiraki K., Takahashi M. Synthesis and processing of glycoproteins of varicella-zoster virus (VZV) as studied with monoclonal antibodies to VZV antigens. Virology 1983, 129(2):357-368.
25. Sadaoka T., Yoshii H., Imazawa T., Yamanishi K., Mori Y. Deletion in open reading frame 49 of varicella-zoster virus reduces virus growth in human malignant melanoma cells but not in human embryonic fibroblasts. J. Virol. 2007, 81(22):12654-12665.
26. Tahara M., Takeda M., Seki F., Hashiguchi T., Yanagi Y. Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently. J. Virol. 2007, 81(6):2564-2572.
27. Takahashi M., Otsuka T., Okuno Y., Asano Y., Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974, 2(7892):1288-1290.
28. Tanaka M., Kagawa H., Yamanashi Y., Sata T., Kawaguchi Y. Construction of an excisable bacterial artificial chromosome containing a full-length infectious clone of herpes simplex virus type 1: viruses reconstituted from the clone exhibit wild-type properties in vitro and in vivo. J. Virol. 2003, 77(2):1382-1391.
29. Tatsuo H., Ono N., Tanaka K., Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000, 406(6798):893-897.
30. Tischer B.K., von Einem J., Kaufer B., Osterrieder N. Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques 2006, 40(2):191-197.
31. Ushijima Y., Koshizuka T., Goshima F., Kimura H., Nishiyama Y. Herpes simplex virus type 2 UL56 interacts with the ubiquitin ligase Nedd4 and increases its ubiquitination. J. Virol. 2008, 82(11):5220-5233.
32. Wattenberg B., Lithgow T. Targeting of C-terminal (tail)-anchored proteins: understanding how cytoplasmic activities are anchored to intracellular membranes. Traffic 2001, 2(1):66-71.
33. Yoshii H., Somboonthum P., Takahashi M., Yamanishi K., Mori Y. Cloning of full length genome of varicella-zoster virus vaccine strain into a bacterial artificial chromosome and reconstitution of infectious virus. Vaccine 2007, 25(27):5006-5012.
34. Yoshii H., Sadaoka K., Matsuura M., Nagaike K., Takahashi M., Yamanishi K., Mori Y. Varicella-zoster virus ORF 58 gene is dispensable for viral replication in cell culture. Virol. J. 2008, 5:54.
35. Zhang Z., Rowe J., Wang W., Sommer M., Arvin A., Moffat J., Zhu H. Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. J. Virol. 2007, 81(17):9024-9033.